Negócios · 19/06/19981 min de leitura
Knickerbocker Biologicals, Inc.; Revocation of U.S. License No. 458-001
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 458-001) and the product licenses issued to Knickerbocker Biologicals, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, and Source Leukocytes. Knickerbocker Biologicals, Inc., did not respond to a notice of opportunity for a hearing on a proposal to revoke its licenses.